Tibet Weixinkang Medicine Co Ltd (603676) — Cash Flow-to-Debt Ratio
Tibet Weixinkang Medicine Co Ltd (603676) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥13.68 Million could theoretically repay 0% of its total liabilities (CN¥382.95 Million) in one year. See Tibet Weixinkang Medicine Co Ltd (603676) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tibet Weixinkang Medicine Co Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Tibet Weixinkang Medicine Co Ltd across 13 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tibet Weixinkang Medicine Co Ltd.
Annual Cash Flow-to-Debt Ratio for Tibet Weixinkang Medicine Co Ltd (2013–2025)
Year-by-year debt coverage analysis for Tibet Weixinkang Medicine Co Ltd. Check earnings quality score of Tibet Weixinkang Medicine Co Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.48x | CN¥185.53 Million | CN¥390.49 Million | ▼ -40.3% |
| 2024 | 0.80x | CN¥372.78 Million | CN¥468.24 Million | ▲ +35.4% |
| 2023 | 0.59x | CN¥256.67 Million | CN¥436.55 Million | ▲ +6.1% |
| 2022 | 0.55x | CN¥246.15 Million | CN¥444.13 Million | ▲ +39.1% |
| 2021 | 0.40x | CN¥170.69 Million | CN¥428.31 Million | ▲ +12.3% |
| 2020 | 0.35x | CN¥133.70 Million | CN¥376.85 Million | ▲ +25.0% |
| 2019 | 0.28x | CN¥106.34 Million | CN¥374.56 Million | ▲ +15.2% |
| 2018 | 0.25x | CN¥83.17 Million | CN¥337.33 Million | ▼ -38.2% |
| 2017 | 0.40x | CN¥63.30 Million | CN¥158.58 Million | ▼ -64.3% |
| 2016 | 1.12x | CN¥103.79 Million | CN¥92.94 Million | ▲ +3.2% |
| 2015 | 1.08x | CN¥114.47 Million | CN¥105.82 Million | ▼ -29.6% |
| 2014 | 1.54x | CN¥118.47 Million | CN¥77.09 Million | ▲ +6.7% |
| 2013 | 1.44x | CN¥88.59 Million | CN¥61.52 Million | — |